GLP Watchdog

Fridays vs Noom

Neither Fridays nor Noom has an FDA warning letter on record. On brand-name tirzepatide pen, Noom costs $17,748 less a year at standing rates: $349 a month against $1,828 a month at Fridays. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Fridays / Noom

Fridays logo

Fridays

5.8/10

Noom logo

Noom

5.8/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$249/moCompounded semaglutide injection
$179/moCompounded semaglutide injection
States
No state list published
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Fridays
Visit Noom

Neither Fridays nor Noom pays us. Links to them earn nothing. Scores: Fridays 5.8, Noom 5.8. How we are paid

What the record shows

  1. 01

    Neither Fridays nor Noom has an FDA warning letter on record.

  2. 02

    Fridays names four pharmacies. Noom names no compounding pharmacy in our record.

  3. 03

    On brand-name tirzepatide pen, Noom costs $17,748 less a year at standing rates: $349 a month against $1,828 a month at Fridays. It is one of two products the two sell at comparable terms.

  4. 04

    Only Fridays lists a price for compounded tirzepatide injection and brand-name semaglutide pen.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Fridays

Noom

Compounded semaglutide injection

$249/mo

$2,988 a year

$179/moLower

$2,148 a year

Brand-name tirzepatide pen

$1,828/mo

$21,936 a year

$349/moLower

$4,188 a year

Compounded tirzepatide injection

$359/mo

$4,308 a year

Not sold or not priced
Brand-name semaglutide pen

$1,498/mo

$17,976 a year

Not sold or not priced
Price includes
Medication, clinician visits, coaching
Clinician visits, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; 3, 6 and 12-month plans are prepaid
Not stated
Refunds
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
Refunds only before a prescription is written; renewal charges are not refunded

Read off each seller’s own pages. Fridays: October 30, 2026. Noom: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Fridays

5.8/10
  • Sells compounded tirzepatide injection and brand-name semaglutide pen, which Noom does not price
  • Names its compounding pharmacy
Visit Fridays

The case for Noom

5.8/10
  • $840 a year less on compounded semaglutide injection
  • $17,748 a year less on brand-name tirzepatide pen
  • Names no compounding pharmacy
Visit Noom

Scores

Fridays 5.8 · Noom 5.8 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
0.9

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

5.5A
vs
B
6.5

Accessibility10%

5.0A
vs
B
5.0

Support10%

7.0A
vs
B
4.0

The score is the same formula for every seller. Payment does not enter it. Method

Fridays vs Noom: questions

Neither Fridays nor Noom has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. Noom names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Noom, by $840 a year at standing rates. Fridays: $249 a month, about $2,988 a year. Noom: $179 a month, about $2,148 a year.
Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires. Noom states you can cancel at any time; refunds: refunds only before a prescription is written; renewal charges are not refunded.
Neither Fridays nor Noom pays us. Links to them earn nothing. Scores: Fridays 5.8, Noom 5.8.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks